Newsquawk Logo

GSK (GSK LN) is in talks to buy cancer biotech Nuvalent (NUVL) for more than USD 9bln, according to FT

ByNewsquawk Staff
Trade the TapeGet this analysis live, the moment it breaksNewsquawk's real-time dashboard delivers market-moving headlines and instant context to your desk before the rest of the market reacts.
Open Dashboard
#UNITED STATES#USD#EUR#JAPAN#JPY#UNITED KINGDOM#GBP#EUROPE#GLAXOSMITHKLINE PLC#GSK.LN#FOREX#EQUITIES#METALS#ASIAN SESSION#PHARMACEUTICALS#METALS & MINING#PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#FTSE 100 INDEX#GSK PLC#GSK#DXY#GLOBAL EQUITIES
External
Published: Updated:
Newsquawk Logo

© 2026 Newsquawk. All rights reserved.